Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Afshan Siddiq

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
Cancer Research|March 4, 2010
Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancerStella Koutros, Fredrick R Schumacher, Richard B Hayes, et al.
Breast Cancer Research : BCR|June 14, 2015
Genetic risk variants associated with in situ breast cancerDaniele Campa, Myrto Barrdahl, Mia M Gaudet, et al.
Oncology Reports|July 5, 2011
Genetic variability of the forkhead box O3 and prostate cancer risk in the European Prospective Investigation on CancerDaniele Campa, Anika Hüsing, Lucie Dostal, et al.
International Journal of Cancer|September 12, 2012
Genetic variation in the lactase gene, dairy product intake and risk for prostate cancer in the European prospective investigation into cancer and nutritionRuth C Travis, Paul N Appleby, Afshan Siddiq, et al.
American Journal of Epidemiology|March 31, 2012
Interactions between genome-wide significant genetic variants and circulating concentrations of insulin-like growth factor 1, sex hormones, and binding proteins in relation to prostate cancer risk in the National Cancer Institute Breast and Prostate Cancer Cohort ConsortiumKonstantinos K Tsilidis, Ruth C Travis, Paul N Appleby, et al.
Journal of the National Cancer Institute|May 15, 2014
Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survivalYin Cao, Sara Lindström, Fredrick Schumacher, et al.
Plos One|March 5, 2011
Genetic variability of the mTOR pathway and prostate cancer risk in the European Prospective Investigation on Cancer (EPIC)Daniele Campa, Anika Hüsing, Angelika Stein, et al.
Journal of the National Cancer Institute|September 12, 2014
Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studiesFrancesca L Crowe, Paul N Appleby, Ruth C Travis, et al.
European Urology|January 14, 2014
Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort ConsortiumIrene M Shui, Sara Lindström, Adam S Kibel, et al.
Cancer Causes & Control : CCC|June 8, 2012
Prediagnostic concentrations of plasma genistein and prostate cancer risk in 1,605 men with prostate cancer and 1,697 matched control participants in EPICRuth C Travis, Naomi E Allen, Paul N Appleby, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Cancer Research|March 4, 2010
Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancerStella Koutros, Fredrick R Schumacher, Richard B Hayes, et al.
Breast Cancer Research : BCR|June 14, 2015
Genetic risk variants associated with in situ breast cancerDaniele Campa, Myrto Barrdahl, Mia M Gaudet, et al.
Oncology Reports|July 5, 2011
Genetic variability of the forkhead box O3 and prostate cancer risk in the European Prospective Investigation on CancerDaniele Campa, Anika Hüsing, Lucie Dostal, et al.
International Journal of Cancer|September 12, 2012
Genetic variation in the lactase gene, dairy product intake and risk for prostate cancer in the European prospective investigation into cancer and nutritionRuth C Travis, Paul N Appleby, Afshan Siddiq, et al.
American Journal of Epidemiology|March 31, 2012
Interactions between genome-wide significant genetic variants and circulating concentrations of insulin-like growth factor 1, sex hormones, and binding proteins in relation to prostate cancer risk in the National Cancer Institute Breast and Prostate Cancer Cohort ConsortiumKonstantinos K Tsilidis, Ruth C Travis, Paul N Appleby, et al.
Journal of the National Cancer Institute|May 15, 2014
Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survivalYin Cao, Sara Lindström, Fredrick Schumacher, et al.
Plos One|March 5, 2011
Genetic variability of the mTOR pathway and prostate cancer risk in the European Prospective Investigation on Cancer (EPIC)Daniele Campa, Anika Hüsing, Angelika Stein, et al.
Journal of the National Cancer Institute|September 12, 2014
Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studiesFrancesca L Crowe, Paul N Appleby, Ruth C Travis, et al.
European Urology|January 14, 2014
Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort ConsortiumIrene M Shui, Sara Lindström, Adam S Kibel, et al.
Cancer Causes & Control : CCC|June 8, 2012
Prediagnostic concentrations of plasma genistein and prostate cancer risk in 1,605 men with prostate cancer and 1,697 matched control participants in EPICRuth C Travis, Naomi E Allen, Paul N Appleby, et al.
Pageof 9